# Tyra Biosciences, Inc.: Form 8-K, filed Jun 2, 2026

- Company: [Tyra Biosciences, Inc.](/companies/tyra.md) (CIK 1863127)
- Form: 8-K
- Filed: 2026-06-02
- Accepted by EDGAR: Jun 2, 2026, 16:01 ET
- Period: 2026-05-28
- Accession: 0001193125-26-253435
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/d33725d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/d33725d8k.htm

Filed Jun 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-253435. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.
